Norris Medicines Limited (BOM:524414)

Norris Medicines Revenue

Norris Medicines had revenue of 32.67M INR in the quarter ending December 31, 2025, with 195.35% growth. This brings the company's revenue in the last twelve months to 94.44M, up 105.90% year-over-year. In the fiscal year ending March 31, 2025, Norris Medicines had annual revenue of 58.20M with 3.27% growth.

• Revenue (ttm): 94.44M
• Revenue Growth: +105.90%
• P/S Ratio: 1.38
• Revenue / Employee: 2.86M
• Employees: 33
• Market Cap: 130.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	58.20M	1.85M	3.27%
Mar 31, 2024	56.36M	-27.23M	-32.58%
Mar 31, 2023	83.59M	-10.80M	-11.44%
Mar 31, 2022	94.38M	-28.13M	-22.96%
Mar 31, 2021	122.51M	44.07M	56.19%